Quarterly report pursuant to Section 13 or 15(d)

Statements of Stockholders' Equity

v3.20.1
Statements of Stockholders' Equity - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Total
Beginning balance, shares at Dec. 31, 2018 9,291,421        
Beginning balance, amount at Dec. 31, 2018 $ 9,291 $ 28,567,221 $ (2,396) $ (21,655,712) $ 6,918,404
Non-cash stock compensation   233,776     233,776
Net loss       (1,376,235) (1,376,235)
Accumulated other comprehensive gain (loss)     (2,127)   (2,127)
Ending balance, shares at Mar. 31, 2019 9,291,421        
Ending balance, amount at Mar. 31, 2019 $ 9,291 28,800,997 (4,523) (23,031,947) 5,773,818
Beginning balance, shares at Dec. 31, 2019 10,587,632        
Beginning balance, amount at Dec. 31, 2019 $ 10,587 38,508,825 (10,970) (25,880,586) 12,627,856
Non-cash stock compensation   338,497     338,497
Issuance of common stock under a Capital on DemandTM Sales Agreement with Jones Trading Institutional Services LLC, net of $16,284 in commissions, shares 33,903        
Issuance of common stock under a Capital on DemandTM Sales Agreement with Jones Trading Institutional Services LLC, net of $16,284 in commissions, amount $ 34 526,109     526,143
Issuance of common stock to non-employee directors pursuant to vested restricted stock units, shares 1,288        
Issuance of common stock to non-employee directors pursuant to vested restricted stock units, amount $ 1 (1)      
Offering costs   (2,161)     (2,161)
Net loss       (1,090,877) (1,090,877)
Accumulated other comprehensive gain (loss)     (4,041)   (4,041)
Ending balance, shares at Mar. 31, 2020 10,622,823        
Ending balance, amount at Mar. 31, 2020 $ 10,622 $ 39,371,269 $ (15,011) $ (26,971,463) $ 12,395,417